Hypertension and it's level of prevention from preventive social medicine

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
I now have all the material needed for a comprehensive answer. Let me compile the full response from Park's Textbook of Preventive and Social Medicine.

Hypertension and Its Levels of Prevention

(Preventive and Social Medicine)

Overview

The low prevalence of hypertension in certain communities confirms that hypertension is potentially preventable. The WHO has recommended a structured framework of prevention with four levels, which can be applied to hypertension:
  1. Primordial Prevention
  2. Primary Prevention
  3. Secondary Prevention
  4. Tertiary Prevention

1. Primordial Prevention

This is the newest concept and is prevention in its purest sense - preventing the very emergence or development of risk factors in populations where they have not yet appeared.
Many adult health problems like obesity and hypertension have their early origins in childhood, because this is when lifestyles are formed (eating patterns, physical activity, smoking). Primordial prevention for hypertension therefore targets children and young people.
Key interventions:
  • Discouraging children from adopting harmful lifestyles
  • Individual and mass health education
  • Avoiding obesogenic environments from early life
  • Promoting healthy eating patterns, physical activity from childhood

2. Primary Prevention

Primary prevention is defined as "all measures to reduce the incidence of disease in a population by reducing the risk of onset." The earlier prevention starts, the more effective it is likely to be. The WHO recommends two complementary strategies:

a. Population (Mass) Strategy

This is directed at the whole population, irrespective of individual risk levels. It is based on the concept that even a small reduction in the average blood pressure of a population would produce a large reduction in the incidence of cardiovascular complications (stroke, CHD). The goal is to shift the community distribution of blood pressure towards lower levels or "biological normality."
Multifactorial non-pharmacological interventions:
InterventionRecommendationApprox. Systolic BP Reduction
Weight reductionMaintain BMI 18.5-24.95-20 mmHg per 10 kg lost
DASH dietRich in fruits, vegetables, low-fat dairy; reduced saturated fat8-14 mmHg
Sodium reductionLimit to ≤5 g/day (≤100 mEq/day)2-8 mmHg
Physical activityRegular aerobic activity, brisk walking ≥30 min/day, most days4-9 mmHg
Alcohol moderation≤2 drinks/day (men), ≤1 drink/day (women)2-4 mmHg
Additional population-level measures include:
  • (a) Nutrition - Reducing salt to ≤5 g/day, moderate fat intake, avoiding excess alcohol, restricting energy intake
  • (b) Weight reduction - Prevention and correction of overweight/obesity (BMI >25)
  • (c) Exercise promotion - Regular physical activity reduces body weight, blood lipids, and blood pressure
  • (d) Behavioural changes - Stress reduction, smoking cessation, yoga, transcendental meditation
  • (e) Health education - Community mobilization and awareness about risk factors
  • (f) Self-care - Teaching patients to measure their own blood pressure and keep a log-book

b. High-Risk Strategy

Also part of primary prevention. Its aim is "to prevent the attainment of levels of blood pressure at which the institution of treatment would be considered." This approach is appropriate when risk factors have very low prevalence in the community.
  • Identifying individuals at risk using clinical methods
  • Detection based on family history of hypertension
  • "Tracking" of blood pressure from childhood (since hypertension clusters in families)
  • Targeting those with prehypertension or multiple cardiovascular risk factors
The two strategies (population and high-risk) are complementary, not mutually exclusive.

3. Secondary Prevention

The goal of secondary prevention is to detect and control high blood pressure in affected individuals before complications arise. Modern antihypertensive drug therapy can effectively reduce BP and consequently the excess risk of morbidity and mortality from coronary, cerebrovascular, and kidney disease.
Control measures comprise three components:

(i) Early Case Detection (Screening)

  • High blood pressure rarely causes symptoms until organ damage has occurred; aim is to control it before this happens
  • The only effective method of diagnosis is population screening
  • Screening must be linked to follow-up and sustained care - screening alone without follow-up is a "fruitless exercise"
  • Should not be initiated if health resources for treatment and follow-up are inadequate
  • In developed countries: Blood pressure should be measured at every health service contact (most people have at least one contact every 2 years)

(ii) Treatment

  • In essential hypertension, we cannot treat the cause (unknown); we aim to reduce BP to acceptable levels
  • Target BP: below 140/90 mmHg; ideally 120/80 mmHg
  • Control of hypertension reduces incidence of stroke and other complications - the major reason for identifying and treating asymptomatic hypertension
  • Care should also involve attention to other risk factors (smoking, elevated blood cholesterol)

(iii) Patient Compliance

  • Treatment of hypertension must normally be life-long - this creates compliance challenges
  • Patient compliance = "the extent to which patient behaviour (taking medicines, following diets, lifestyle changes) coincides with clinical prescription"
  • Compliance rates can be improved through education directed to patients, families, and the community
Community-level control studies have shown that hypertension control is feasible through existing health services, and that blood pressure control leads to reduction in complications - stroke, heart failure, and renal failure.

4. Tertiary Prevention

Tertiary prevention involves rehabilitation and limitation of disability in those already having established hypertension with target organ damage. In the context of hypertension this includes:
  • Management of complications - stroke, heart failure, renal failure, retinopathy
  • Cardiac and neurological rehabilitation after events (myocardial infarction, stroke)
  • Prevention of recurrence of complications (e.g., anticoagulation after stroke, ACE inhibitors after MI)
  • Disability limitation in those with end-organ damage

Summary Table

LevelTargetGoalExamples
PrimordialGeneral population (children/youth)Prevent risk factor emergenceHealth education, healthy lifestyles in childhood
PrimaryAt-risk individuals and whole populationPrevent onset of hypertensionSalt reduction, DASH diet, weight loss, exercise, high-risk screening
SecondaryHypertensives without symptoms/complicationsEarly detection and controlMass screening, antihypertensive drugs, patient compliance
TertiaryHypertensives with target organ damageLimit disability, prevent progressionStroke rehab, heart failure management, renal protection

Source: Park's Textbook of Preventive and Social Medicine (Park, 26th Ed.), Chapter on Cardiovascular Diseases - Hypertension; and Chapter on Concepts of Health and Disease - Levels of Prevention.
This is a shared conversation. Sign in to Orris to start your own chat.